Hepatocellular carcinoma and evidence-based surgery

被引：17

作者：

Braillon, Alain ^{[1
]}

机构：

[1] Univ Hosp, F-80000 Amiens, France

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2009年 / 15卷 / 42期

关键词：

Hepatocellular carcinoma; Evidence based medicine;

D O I：

10.3748/wjg.15.5371

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

Transplantation cannot be considered the most important therapeutic procedure for hepatocellular carcinoma (HCC). In France, no more than 2% of patients with HCC undergo a transplantation. Randomized controlled trial must assess the benefit to risk ratio of various potentially "curative" treatment procedures (transplantation, resection, radio-frequency ablation). (C) 2009 The WIG Press and Baishideng. All rights reserved.

引用

页码：5371 / 5371

页数：1

共 5 条

[1]

*AG BIOM, RAPP ANN 2007

[2]

BRAILLON A, 2008, AM J MED, V121, pE12

[3]

Hepatocellular carcinoma: A pledge for evidence-based medicine [J].